Quercis Pharma AG
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Quercis Pharma AG - overview
Established
2019
Location
Zug, -, Switzerland
Primary Industry
Biotechnology
About
Founded in 2019, and based in Zurg, Switzerland, Quercis Pharma AG operates as a biopharmaceutical company that provides an antithrombotic platform for patients with potentially life-threatening conditions to prevent venous thrombosis and pulmonary embolism.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.quercis.com
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Quercis Pharma AG - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Announced | Quercis Pharma AG | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.